SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-077791
Filing Date
2024-07-03
Accepted
2024-07-03 16:17:37
Documents
13
Period of Report
2024-07-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2418848d1_8k.htm   iXBRL 8-K 32841
  Complete submission text file 0001104659-24-077791.txt   207730

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ibio-20240703.xsd EX-101.SCH 3012
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ibio-20240703_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ibio-20240703_pre.xml EX-101.PRE 22357
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2418848d1_8k_htm.xml XML 3681
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35023 | Film No.: 241100356
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)